dihydroergotamine has been researched along with Disease Models, Animal in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Braisted, J; Dranchak, P; Earnest, TW; Gu, X; Hoon, MA; Inglese, J; Oliphant, E; Solinski, HJ | 1 |
| Argüelles, CF; Godínez-Chaparro, B; Granados-Soto, V; López-Santillán, FJ; Villalón, CM | 1 |
| Buonvicino, D; Chiarugi, A; De Cesaris, F; Muzzi, M | 1 |
| Bourgoin, S; Hamon, M; Kayser, V; Latrémolière, A | 1 |
| Aubel, B; Bourgoin, S; Hamon, M; Kayser, V | 1 |
| Bergqvist, D; Nilsson, B | 1 |
| Filinova, ZS | 1 |
7 other study(ies) available for dihydroergotamine and Disease Models, Animal
| Article | Year |
|---|---|
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
Topics: Animals; Behavior, Animal; Cell-Free System; Dermatitis, Contact; Disease Models, Animal; Ganglia, Spinal; Humans; Mice, Inbred C57BL; Mice, Knockout; Neurons; Pruritus; Receptors, Atrial Natriuretic Factor; Reproducibility of Results; Signal Transduction; Small Molecule Libraries | 2019 |
Role of 5-HT₁B/₁D receptors in the reduction of formalin-induced nociception and secondary allodynia/hyperalgesia produced by antimigraine drugs in rats.
Topics: Acute Pain; Animals; Biphenyl Compounds; Chronic Pain; Dihydroergotamine; Disease Models, Animal; Drug Therapy, Combination; Female; Formaldehyde; Hyperalgesia; Methysergide; Nociceptive Pain; Piperazines; Piperidones; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Serotonin Antagonists; Spiro Compounds; Sumatriptan | 2013 |
Acute and chronic triptan exposure neither alters rodent cerebral blood flow nor worsens ischemic brain injury.
Topics: Animals; Antihypertensive Agents; Brain Ischemia; Cerebral Cortex; Cerebrovascular Circulation; Dihydroergotamine; Disease Models, Animal; Drug Evaluation, Preclinical; Dura Mater; Male; Mice, Inbred C57BL; Prazosin; Pyrrolidines; Random Allocation; Rats, Sprague-Dawley; RNA, Messenger; Serotonin Receptor Agonists; Time Factors; Tryptamines; Vasoconstrictor Agents | 2017 |
N-methyl-D-aspartate receptor-mediated modulations of the anti-allodynic effects of 5-HT1B/1D receptor stimulation in a rat model of trigeminal neuropathic pain.
Topics: Analgesics, Non-Narcotic; Animals; Cycloserine; Dihydroergotamine; Disease Models, Animal; Drug Synergism; Excitatory Amino Acid Antagonists; Hyperalgesia; Male; Motor Activity; Oxazolidinones; Pyrrolidinones; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Sciatica; Serotonin 5-HT1 Receptor Agonists; Trigeminal Neuralgia; Tryptamines | 2011 |
The antimigraine 5-HT 1B/1D receptor agonists, sumatriptan, zolmitriptan and dihydroergotamine, attenuate pain-related behaviour in a rat model of trigeminal neuropathic pain.
Topics: Animals; Dihydroergotamine; Disease Models, Animal; Male; Migraine Disorders; Oxazolidinones; Pain; Pain Threshold; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Serotonin Receptor Agonists; Sumatriptan; Trigeminal Nerve Diseases; Tryptamines | 2002 |
The influence of low molecular weight heparin in combination with dihydroergotamine on experimental thrombosis and haemostasis.
Topics: Animals; Dihydroergotamine; Disease Models, Animal; Drug Evaluation, Preclinical; Female; Hemostasis; Heparin, Low-Molecular-Weight; Male; Rabbits; Thrombosis | 1987 |
Effect of dihydroergotamine on partial functions of the kidneys and water and salt metabolism in dogs with experimental hypertension.
Topics: Animals; Dihydroergotamine; Disease Models, Animal; Diuresis; Dogs; Ergotamine; Glomerular Filtration Rate; Hypertension; Kidney; Natriuresis; Pituitary Hormones, Posterior; Sodium; Vasomotor System; Water-Electrolyte Balance | 1974 |